ELAN R&D to Revenue
Elanco Animal Health Incorporated Common Stock · R&D to Revenue
ELAN R&D to Revenue
Latest reported6.73%period ending
ELAN Quarterly R&D/Revenue (8.90% → 6.73%)
Latest values, visible window
High-resolution chart · PNG
ELAN r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 6.7251% | |
| 7.0751% | |
| 8.1294% | |
| 7.8276% | |
| 7.4134% | |
| 7.8793% | |
| 7.9412% | |
| 8.4466% | |
| 7.5169% | |
| 7.2199% | |
| 7.6329% | |
| 8.0524% | |
| 7.6632% | |
| 6.4439% | |
| 8.0972% | |
| 7.6023% | |
| 6.9787% | |
| 6.6069% | |
| 8.2659% | |
| 8.3112% | |
| 7.3495% | |
| 7.1659% | |
| 9.8886% | |
| 9.9033% | |
| 10.1313% | |
| 10.1566% | |
| 8.5515% | |
| 9.0626% | |
| 8.8025% | |
| 8.7676% | |
| 7.6442% | |
| 7.7388% | |
| 7.972% | |
| 8.8563% | |
| 8.2195% | |
| 8.8796% | |
| 8.8968% | |
| 8.8968% |